PepGen Inc (PEPG)
13.21
-0.44
(-3.22%)
USD |
NASDAQ |
May 17, 16:00
13.21
0.00 (0.00%)
After-Hours: 20:00
PepGen Enterprise Value: 251.39M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 251.39M |
| May 16, 2024 | 267.27M |
| May 15, 2024 | 272.78M |
| May 14, 2024 | 278.29M |
| May 13, 2024 | 255.93M |
| May 10, 2024 | 278.94M |
| May 09, 2024 | 257.22M |
| May 08, 2024 | 268.89M |
| May 07, 2024 | 277.32M |
| May 06, 2024 | 277.00M |
| May 03, 2024 | 285.10M |
| May 02, 2024 | 294.50M |
| May 01, 2024 | 275.38M |
| April 30, 2024 | 222.53M |
| April 29, 2024 | 203.10M |
| April 26, 2024 | 211.19M |
| April 25, 2024 | 203.74M |
| April 24, 2024 | 207.96M |
| April 23, 2024 | 204.39M |
| April 22, 2024 | 193.70M |
| April 19, 2024 | 166.00M |
| April 18, 2024 | 208.43M |
| April 17, 2024 | 197.26M |
| April 16, 2024 | 232.56M |
| April 15, 2024 | 220.90M |
| Date | Value |
|---|---|
| April 12, 2024 | 245.84M |
| April 11, 2024 | 236.45M |
| April 10, 2024 | 210.21M |
| April 09, 2024 | 217.98M |
| April 08, 2024 | 225.11M |
| April 05, 2024 | 209.89M |
| April 04, 2024 | 200.17M |
| April 03, 2024 | 176.85M |
| April 02, 2024 | 247.46M |
| April 01, 2024 | 293.78M |
| March 28, 2024 | 365.20M |
| March 27, 2024 | 345.47M |
| March 26, 2024 | 314.41M |
| March 25, 2024 | 319.58M |
| March 22, 2024 | 372.00M |
| March 21, 2024 | 368.12M |
| March 20, 2024 | 370.70M |
| March 19, 2024 | 341.59M |
| March 18, 2024 | 331.23M |
| March 15, 2024 | 389.15M |
| March 14, 2024 | 339.64M |
| March 13, 2024 | 334.47M |
| March 12, 2024 | 339.00M |
| March 11, 2024 | 346.76M |
| March 08, 2024 | 350.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-103.97M
Minimum
Sep 21 2022
449.33M
Maximum
Mar 04 2024
122.73M
Average
108.09M
Median
Apr 05 2023
Enterprise Value Benchmarks
| Catalyst Pharmaceuticals Inc | 1.637B |
| Vertex Pharmaceuticals Inc | 104.72B |
| Sarepta Therapeutics Inc | 12.27B |
| PTC Therapeutics Inc | 1.938B |
| Regenxbio Inc | 448.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.02M |
| Total Expenses (Quarterly) | 19.80M |
| EPS Diluted (Quarterly) | -0.63 |
| Earnings Yield | -24.62% |